Ankündigung • Jul 06
The Radoff-Jumana Group Issues Presentation to Shareholders of Genesco On July 6, 2026, Bradley L. Radoff announced that he has submitted an investor presentation with the shareholders of Genesco Inc., highlighting how Company’s presentation uses mimi math to cherry-pick a depressed starting share price and artificially high ending share price in order to make the company’s performance appear better than it actually is – stock is down more than 22% since cherry-picked date. In addition, Bradley L. Radoff believes this is the latest example of the board manipulating the facts and calls for Vaughn to be stripped of her board chair role and called on the Company to return excess cash to shareholders via a Dutch tender offer for 1 million shares at the earliest possible opportunity. Further, Bradley L. Radoff requesting the Company shareholders to vote for his nominees Westervelt T. Ballard, Jr. and Paula J. Poskon, recommended the Company shareholders to Joanna Barsh or Thurgood Marshall, at the 2026 annual meeting of shareholders of the Company. Ankündigung • Jul 02
Radoff-Jumana Group Issues a Statement to the Shareholders of Genesco On July 2, 2026, Bradley L. Radoff, Jumana Capital Investments LLC and Christopher R. Martin announced that it had issued statement where it exposes that Genesco’s Proxy Statement falsely claims Joanna Barsh has public company leadership and senior leadership experience – in reality, she has no such experience and should be disqualified from serving on Genesco’s Board and urged shareholders to replace Ms. Barsh and Thurgood Marshall, Jr. With Westervelt T. Ballard, Jr., a Former Public Company CEO, and Paula J. Poskon. Further, Bradley L. Radoff offers to withdraw proxy contest if Ms. Barsh and Mr. Marshall resign immediately and one of our candidates is appointed to the board. In addition, Bradley L. Radoff recommended shareholder to vote for the Radoff-Jumana Group’s Nominees – Westervelt T. Ballard, Jr. and Paula J. Poskon to hold the legacy board accountable for years of value destruction and send a clear signal for change. Valuation Update With 7 Day Price Move • Jun 18
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to US$35.67, the stock trades at a trailing P/E ratio of 20.1x. Average forward P/E is 12x in the Specialty Retail industry in the US. Total returns to shareholders of 46% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$16.10 per share. Ankündigung • Jun 16
Genesco Inc., Annual General Meeting, Jul 21, 2026 Genesco Inc., Annual General Meeting, Jul 21, 2026. New Risk • Jun 01
New major risk - Revenue and earnings growth Earnings have declined by 60% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Reported Earnings • May 29
First quarter 2027 earnings released: US$1.42 loss per share (vs US$2.02 loss in 1Q 2026) First quarter 2027 results: US$1.42 loss per share (improved from US$2.02 loss in 1Q 2026). Revenue: US$487.0m (up 2.8% from 1Q 2026). Net loss: US$14.8m (loss narrowed 30% from 1Q 2026). Revenue is forecast to grow 1.5% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Specialty Retail industry in the US. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 27% per year, which means it is well ahead of earnings. Price Target Changed • May 27
Price target decreased by 8.8% to US$34.67 Down from US$38.00, the current price target is an average from 3 analysts. New target price is 6.8% below last closing price of US$37.18. Stock is up 71% over the past year. The company posted earnings per share of US$1.28 last year. Valuation Update With 7 Day Price Move • May 26
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to US$37.38, the stock trades at a trailing P/E ratio of 30.6x. Average forward P/E is 11x in the Specialty Retail industry in the US. Total returns to shareholders of 103% over the past three years. Ankündigung • May 15
Genesco Inc. to Report Q1, 2027 Results on May 29, 2026 Genesco Inc. announced that they will report Q1, 2027 results Pre-Market on May 29, 2026 Ankündigung • May 08
Genesco Inc. Appoints Ashley Randolph as Chief Accounting Officer, Effective May 5, 2026 Genesco Inc. announced the appointment of Ashley Randolph as Vice President and Chief Accounting Officer, effective May 5, 2026. 20-year veteran of Genesco, Randolph most recently served as Vice President and Corporate Controller, a role she has held since 2024. In her new role, Randolph will oversee the Company’s accounting operations, financial controls and compliance, including financial statements, accounting policy, and SEC reporting, while driving continued efficiencies across the function. During her tenure, Randolph has played a key role in strengthening Genesco’s financial foundation and advancing operational effectiveness, including leading the adoption of new accounting standards, modernizing SEC reporting processes and enhancing internal controls. She served as Senior Director, Finance and Accounting from 2018 to 2024 and Director, Finance and Accounting from 2016 to 2018. She held roles of increasing responsibility with the Company in technical accounting and financial compliance from 2004 to 2014. Prior to joining Genesco, Randolph was a senior auditor at Deloitte & Touche. She holds a bachelor’s degree in accounting from Lipscomb University and is a Certified Public Accountant. Ankündigung • Mar 28
Genesco Inc. Announces Changes in Principal Accounting Officer As previously announced on January 29, 2026, Genesco Inc. and the Company’s former Senior Vice President and Chief Financial Officer, Cassandra E. Harris, entered into a Consulting Agreement dated January 29, 2026, pursuant to which Ms. Harris continued to support the Company as a consultant and principal accounting officer from March 7, 2026, through the filing of the Company’s fiscal year 2026 Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 25, 2026 (the ‘ Form 10-K ‘), assisting with an orderly transition. Accordingly, Ms. Harris ceased to serve as the Company's principal accounting officer, effective March 25, 2026. On March 26, 2026, Mimi E. Vaughn, age 59, the Company’s President, Chief Executive Officer, Interim Chief Financial Officer and principal financial officer, was appointed by the Company’s board of directors to serve as the Company’s principal accounting officer until the Company names a successor. Ms. Vaughn will continue to lead the Company’s experienced financial leadership team and management in connection with her service as Interim Chief Financial Officer. Reported Earnings • Mar 09
Full year 2026 earnings released: EPS: US$1.28 (vs US$1.80 loss in FY 2025) Full year 2026 results: EPS: US$1.28 (up from US$1.80 loss in FY 2025). Revenue: US$2.44b (up 4.8% from FY 2025). Net income: US$13.3m (up US$32.8m from FY 2025). Profit margin: 0.5% (up from net loss in FY 2025). Like-for-like sales growth: 6.0% vs FY 2025 Revenue is forecast to grow 1.4% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Specialty Retail industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance. Price Target Changed • Mar 08
Price target decreased by 7.9% to US$35.00 Down from US$38.00, the current price target is an average from 4 analysts. New target price is 32% above last closing price of US$26.50. Stock is down 2.3% over the past year. The company posted a net loss per share of US$1.80 last year. Ankündigung • Mar 06
Genesco Inc. Provides Earnings Guidance for the Year 2027 Genesco Inc. provided earnings guidance for the year 2027 . For the year, company Expects positive comparable sales of 1% to 2% Expects total sales to be down 1% to flat compared to Fiscal 2026 including a reduction in sales of approximately $30 million net due to the exit of licenses and approximately $30 million related to net store closures . Ankündigung • Feb 19
Genesco Inc. to Report Q4, 2026 Results on Mar 06, 2026 Genesco Inc. announced that they will report Q4, 2026 results Pre-Market on Mar 06, 2026 Board Change • Feb 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. 2 highly experienced directors. Independent Director Matt Bilunas was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Price Target Changed • Jan 13
Price target increased by 16% to US$35.25 Up from US$30.33, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of US$34.56. Stock is down 17% over the past year. The company posted a net loss per share of US$1.80 last year. Ankündigung • Jan 13
Genesco Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2026 Genesco Inc. provided earnings guidance for the Fiscal Year Ending January 31, 2026. For the year, the company expects Forecasted earnings from continuing operations of Net of Tax was $7.3 million and Per share was $0.68. Price Target Changed • Dec 30
Price target decreased by 7.1% to US$30.33 Down from US$32.67, the current price target is an average from 3 analysts. New target price is 20% above last closing price of US$25.36. Stock is down 41% over the past year. The company posted a net loss per share of US$1.80 last year. Ankündigung • Dec 04
Genesco Inc. Revises Earnings Guidance for the Fiscal Year Ending January 31, 2026 Genesco Inc. revised earnings guidance for the fiscal year 2026. For the year, the company expects total sales to be up about 2% and comparable sales to be up about 3% compared to Fiscal 2025, down from prior guidance for total sales to be up 3% to 4% and comparable sales up 4% to 5%. Ankündigung • Nov 21
Genesco Inc. to Report Q3, 2026 Results on Dec 04, 2025 Genesco Inc. announced that they will report Q3, 2026 results Pre-Market on Dec 04, 2025 Reported Earnings • Aug 28
Second quarter 2026 earnings released: US$1.79 loss per share (vs US$0.91 loss in 2Q 2025) Second quarter 2026 results: US$1.79 loss per share (further deteriorated from US$0.91 loss in 2Q 2025). Revenue: US$546.0m (up 4.0% from 2Q 2025). Net loss: US$18.5m (loss widened 86% from 2Q 2025). Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Specialty Retail industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 103 percentage points per year, which is a significant difference in performance. Ankündigung • Aug 28
Genesco Inc. Provides Earnings Guidance for the Fiscal Year 2026 Genesco Inc. provided earnings guidance for the fiscal year 2026. For the year, the company expects total sales to be up 3% to 4% compared to Fiscal 2025 with comparable sales range up 4% to 5%, up from prior guidance for total sales to be up 1% to 2% and comparable sales up 2% to 3%. Price Target Changed • Aug 26
Price target increased by 23% to US$29.00 Up from US$23.50, the current price target is an average from 3 analysts. New target price is 9.8% below last closing price of US$32.16. Stock is up 4.8% over the past year. The company posted a net loss per share of US$1.80 last year. Ankündigung • Aug 21
Genesco Inc. to Report Q2, 2026 Results on Aug 28, 2025 Genesco Inc. announced that they will report Q2, 2026 results Pre-Market on Aug 28, 2025 Reported Earnings • Jun 04
First quarter 2026 earnings released: US$2.02 loss per share (vs US$2.22 loss in 1Q 2025) First quarter 2026 results: US$2.02 loss per share (improved from US$2.22 loss in 1Q 2025). Revenue: US$474.0m (up 3.6% from 1Q 2025). Net loss: US$21.2m (loss narrowed 13% from 1Q 2025). Revenue is forecast to grow 1.4% p.a. on average during the next 2 years, compared to a 5.1% growth forecast for the Specialty Retail industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance. New Risk • Jun 04
New major risk - Revenue and earnings growth Earnings have declined by 1.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.4% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (13% average weekly change). Ankündigung • Jun 04
Genesco Inc. Revises Earnings Guidance for the Fiscal Year Ending January 31, 2026 Genesco Inc. revised earnings guidance for the fiscal year ending January 31, 2026. For the year, the company expects earnings from continuing operations net of tax of $12.5 million to $17.0 million and earnings from continuing operations to be $1.17 per share to $1.61 per share. Expects total sales to be up 1% to 2% compared to Fiscal 2025 versus prior expectation of flat to up 1% due to the impact of favorable foreign exchange, with comparable sales range narrowed to up 2% to 3% versus prior range of up 2% to 4%. Ankündigung • May 20
Genesco Inc. to Report Q1, 2026 Results on Jun 04, 2025 Genesco Inc. announced that they will report Q1, 2026 results Pre-Market on Jun 04, 2025 Ankündigung • May 19
Genesco Inc., Annual General Meeting, Jun 26, 2025 Genesco Inc., Annual General Meeting, Jun 26, 2025. Buy Or Sell Opportunity • Apr 09
Now 29% overvalued Over the last 90 days, the stock has fallen 51% to US$20.42. The fair value is estimated to be US$15.82, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. New Risk • Apr 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.4% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (11% average weekly change). Buy Or Sell Opportunity • Mar 25
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 45% to US$22.59. The fair value is estimated to be US$28.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Recent Insider Transactions • Mar 21
Independent Director recently bought US$252k worth of stock On the 20th of March, Gregory Sandfort bought around 11k shares on-market at roughly US$22.92 per share. This transaction amounted to 38% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought US$81k more in shares than they have sold in the last 12 months. Ankündigung • Mar 08
Genesco Inc. Provides Earnings Guidance for the Year 2026 Genesco Inc. provided earnings guidance for the year 2026. For the year, the company expects total sales to be flat to up 1% compared to Fiscal 2025 including a foreign exchange negative impact of approximately $14 million and closed store impact of approximately $30 million.
. Reported Earnings • Mar 07
Full year 2025 earnings released: US$1.80 loss per share (vs US$2.10 loss in FY 2024) Full year 2025 results: US$1.80 loss per share (improved from US$2.10 loss in FY 2024). Revenue: US$2.33b (flat on FY 2024). Net loss: US$19.5m (loss narrowed 17% from FY 2024). Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Specialty Retail industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance. Buy Or Sell Opportunity • Mar 04
Now 23% undervalued after recent price drop Over the last 90 days, the stock has fallen 14% to US$32.97. The fair value is estimated to be US$43.03, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Ankündigung • Feb 21
Genesco Inc. to Report Q4, 2025 Results on Mar 07, 2025 Genesco Inc. announced that they will report Q4, 2025 results Pre-Market on Mar 07, 2025 Buy Or Sell Opportunity • Feb 13
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 36% to US$40.11. The fair value is estimated to be US$32.82, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Ankündigung • Jan 09
Genesco Inc. Appoints Kyle Polischuk as Chief Human Resources Officer Genesco Inc. announced that Kyle Polischuk has been named Chief Human Resources Officer, leading the enterprise wide human resources function for the footwear focused lifestyle retailer and branded company. In this newly created role, Polischuk will leverage her 20+ years of strategic human resources experience overseeing Genesco’s HR initiatives, including talent management and recruitment, leadership development, performance management, employee engagement and total rewards. Polischuk will report to Vaughn and serve on Genesco’s executive management committee. Her appointment is effective January 6, 2025. Polischuk has a deep background in consumer, retail and human resources. She joins Genesco from Rue Gilt Group, a leading off-price ecommerce portfolio company, where she was responsible for the company’s people and talent strategy and its connection to business goals. Prior to Rue Gilt, she held various leadership roles, including as Chief Human Resources officer with J. Jill leading the overall strategic direction of the company’s talent with a creative, collaborative and data centric approach, while aligning with the company’s strategic objectives. Previous positions include at Talbots where she served in successive roles including vice president, human resources, where she led the total scope of human resources, including serving on the executive committee during the specialty retailer’s major business turnaround. Recent Insider Transactions • Dec 18
Insider recently sold US$171k worth of stock On the 17th of December, Daniel Ewoldsen sold around 4k shares on-market at roughly US$42.68 per share. This transaction amounted to 8.8% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Ankündigung • Dec 14
Genesco Inc. Announces Executive Changes Genesco Inc. reported that in conjunction with Mr. Thomas A. George’s retirement, Ms. Cassandra “Sandra” Harris will succeed Mr. George as principal accounting officer, effective December 12, 2024. Prior to joining the Company, Ms. Harris, age 52, served as Chief Financial Officer of Artisan Design Group, LLC from February 2023 to April 2024. Previously, Ms. Harris served as Tupperware Brands Corp.’s (“Tupperware”) (i) Chief Financial Officer and Chief Operating Officer from October 2020 to June 2022 and (ii) Executive Vice President and Chief Financial Officer from April 2019 to October 2020. Prior to joining Tupperware, Ms. Harris served in multiple senior leadership roles with V.F. Corporation from March 2008 to March 2019. Ms. Harris holds a Bachelor of Science in Accounting from Clemson University and is a Certified Public Accountant and Chartered Global Management Accountant. Price Target Changed • Dec 09
Price target increased by 38% to US$40.00 Up from US$29.00, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of US$41.66. Stock is up 35% over the past year. The company posted a net loss per share of US$2.10 last year. New Risk • Dec 06
New major risk - Revenue and earnings growth Earnings have declined by 0.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Reported Earnings • Dec 06
Third quarter 2025 earnings released: US$1.76 loss per share (vs US$0.60 profit in 3Q 2024) Third quarter 2025 results: US$1.76 loss per share (down from US$0.60 profit in 3Q 2024). Revenue: US$596.3m (up 2.9% from 3Q 2024). Net loss: US$18.8m (down 386% from profit in 3Q 2024). Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Specialty Retail industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 87 percentage points per year, which is a significant difference in performance. Ankündigung • Dec 06
Genesco Inc. Raises Earnings Guidance for the Fiscal Year 2025 Genesco Inc. raised earnings guidance for the fiscal year 2025. For the period, the company expects Now expects total sales to be down 1% to flat compared to Fiscal 2024, or flat to up 1% excluding the 53 week in Fiscal 2024 versus prior expectations for a total sales decrease of 1% to 2%, or flat to down 1% excluding the 53rd week in Fiscal 2024. Ankündigung • Nov 21
Genesco Inc. to Report Q3, 2025 Results on Dec 06, 2024 Genesco Inc. announced that they will report Q3, 2025 results Pre-Market on Dec 06, 2024 Reported Earnings • Sep 07
Second quarter 2025 earnings released: US$0.91 loss per share (vs US$2.79 loss in 2Q 2024) Second quarter 2025 results: US$0.91 loss per share (improved from US$2.79 loss in 2Q 2024). Revenue: US$525.2m (flat on 2Q 2024). Net loss: US$9.93m (loss narrowed 69% from 2Q 2024). Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Specialty Retail industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance. Ankündigung • Aug 26
Genesco Inc. to Report Q2, 2025 Results on Sep 06, 2024 Genesco Inc. announced that they will report Q2, 2025 results Pre-Market on Sep 06, 2024 Ankündigung • Jul 23
Journeys Announces the Appointment of Stacy Doren as Executive Vice President and Chief Marketing Officer, Effective August 1, 2024 Journeys announced the appointment of Stacy Doren as Executive Vice President and Chief Marketing Officer of the Journeys Group, effective August 1, 2024. An accomplished global brand executive, Doren will lead all marketing functions, building on Journeys' foundation as a leader in teen fashion footwear retail. Doren joins Journeys after an impressive 24-year tenure at Levi’s, where she held successive leadership roles, culminating in a decade-long role as Vice President of Levi's Americas Marketing. Most recently, she led a 50-person marketing team overseeing creative development, media, partnerships and activations, public relations, channel marketing, and brand environment for the company's largest business segment. Under her guidance, she crafted and executed innovative marketing strategies that strengthened consumer affinity and drove commercial success. Her achievements include developing Levi’s full-funnel marketing offense, re-establishing the brand's cultural relevance with youth, helping to rejuvenate the women's business and grow lifestyle categories, and overseeing the high-profile launch of Levi’s stadium. Reported Earnings • Jun 04
First quarter 2025 earnings released: US$2.22 loss per share (vs US$1.60 loss in 1Q 2024) First quarter 2025 results: US$2.22 loss per share (further deteriorated from US$1.60 loss in 1Q 2024). Revenue: US$457.6m (down 5.3% from 1Q 2024). Net loss: US$24.3m (loss widened 29% from 1Q 2024). Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Specialty Retail industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 47 percentage points per year, which is a significant difference in performance. Ankündigung • May 31
Genesco Inc. Reaffirms Earnings Guidance for the Year 2025 Genesco Inc. reaffirmed earnings guidance for the year 2025. For Fiscal 2025, the Company: Continues to expect total sales to decrease 2% to 3% compared to Fiscal 2024, or down 1% to 2% excluding the 53rd week in Fiscal 2024. Forecasted earnings from continuing operations of $4.0 million to $9.0 million and $0.36 to $0.80 per share. Ankündigung • May 21
Genesco Inc., Annual General Meeting, Jun 27, 2024 Genesco Inc., Annual General Meeting, Jun 27, 2024. Ankündigung • May 18
Genesco Inc. to Report Q1, 2025 Results on May 31, 2024 Genesco Inc. announced that they will report Q1, 2025 results Pre-Market on May 31, 2024 Reported Earnings • Mar 10
Full year 2024 earnings released: US$2.10 loss per share (vs US$5.80 profit in FY 2023) Full year 2024 results: US$2.10 loss per share (down from US$5.80 profit in FY 2023). Revenue: US$2.32b (down 2.5% from FY 2023). Net loss: US$23.6m (down 133% from profit in FY 2023). Like-for-like sales growth: Down 7.0% vs FY 2023 Revenue is expected to decline by 2.2% p.a. on average during the next 2 years, while revenues in the Specialty Retail industry in the US are expected to grow by 5.2%. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings. Ankündigung • Mar 08
Genesco Inc. Provides Revenue Guidance for Fiscal 2025 Genesco Inc. provided revenue guidance for fiscal 2025. For the period, the company expects total sales to decrease 2% to 3% compared to Fiscal 2024, or down 1% to 2% excluding the 53rdweek in Fiscal 2024. Ankündigung • Feb 27
Genesco Inc. to Report Q4, 2024 Results on Mar 08, 2024 Genesco Inc. announced that they will report Q4, 2024 results Pre-Market on Mar 08, 2024 Buy Or Sell Opportunity • Feb 10
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 2.4% to US$29.75. The fair value is estimated to be US$24.71, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.3% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Jan 22
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 2.0% to US$27.76. The fair value is estimated to be US$23.07, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.3% over the last 3 years. Meanwhile, the company became loss making. Ankündigung • Jan 05
Genesco Names Chris Santaella as Executive Vice President and Chief Merchandising Officer of Journeys Group, Effective February 5, 2024 Genesco Inc. announced the appointment of Chris Santaella as executive vice president and chief merchandising officer of the Journeys Group, effective February 5, 2024. Santaella replaces Pete Hicks who retired in October 2023. An accomplished and diversified global merchant, Santaella will lead Journeys’ buying, merchandising, planning and product strategies, building on Journeys foundation as a leader in teen fashion footwear retail and its brand mission of “an attitude you can wear” self-expression inspired by youth culture. Santaella joins Journeys from Foot Locker, where he served more than three decades in successive roles, most recently as senior vice president and chief merchandising officer responsible for Foot Locker, Kids Foot Locker and Champs Sports. He led a 125-person global product organization which included divisional buying teams, global product development and product strategy teams. In this role he developed and implemented global product strategies to drive and diversify Foot Locker’s business model, including successfully expanding Foot Locker’s brand portfolio through a curated consumer focused approach. Santaella will report to Andy Gray, Journeys president. Santaella joins Genesco from Foot Locker where he served in a variety of senior leadership positions. From his early career as a buyer and merchandiser, he rose through the ranks to vice president of footwear, responsible for buying for men’s Foot Locker and Lady Foot Locker, and subsequently to vice president and general merchandise manager for Foot Locker, Kids Foot Locker, Lady Foot Locker and Footaction. He later took on the more senior roles of vice president and general manager North America for Kids Foot Locker, where he led the team across all functions including product, planning, allocation, marketing and finance, followed by vice president and chief product strategist for Foot Locker North America, where he was responsible for developing and leading a new merchant organization to transform a legacy product organization. Santaella rounded out his career at Foot Locker as senior vice president and chief product officer, and finally chief merchandising officer. New Risk • Dec 03
New major risk - Revenue and earnings growth Earnings have declined by 0.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Reported Earnings • Dec 03
Third quarter 2024 earnings released: EPS: US$0.60 (vs US$1.68 in 3Q 2023) Third quarter 2024 results: EPS: US$0.60 (down from US$1.68 in 3Q 2023). Revenue: US$579.3m (down 4.1% from 3Q 2023). Net income: US$6.59m (down 68% from 3Q 2023). Profit margin: 1.1% (down from 3.4% in 3Q 2023). Revenue is forecast to grow 2.3% p.a. on average during the next 2 years, compared to a 5.6% growth forecast for the Specialty Retail industry in the US. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.